PR and Ki‐67 have prognostic value in breast cancer,5, 37, 38 and we show that ultralow risk tumors are significantly more likely to be PR‐positive and Ki‐67‐low (<15%), as determined by IHC. This evidence concerns the gene MKI67 and breast carcinoma.